TPM2 and posterior cortical atrophy: The reduced expression of TPM2 in PCa patient tumor tissues is significantly correlated with a less favorable prognosis, suggesting that downregulation of TPM2 predicts poor outcomes for PCa patients (Varisli, 2013).